Breaking News
January 23, 2019 - Short interval between last meal of the day and bedtime may not affect blood glucose levels
January 23, 2019 - Still Too Many Highway Deaths Tied to Speeding
January 23, 2019 - Prenatal valproate exposure linked to increased ADHD risk
January 23, 2019 - Compound identified that may help treat heart failure
January 23, 2019 - Undiagnosed Asthma in Urban Adolescents May Be Common
January 23, 2019 - Study describes metabolism of intestinal microbiota in babies for the first time
January 22, 2019 - Study links concussions to development of epilepsy
January 22, 2019 - Specialist-led hospital bereavement service may help restrain legal action after difficult deaths
January 22, 2019 - Genetic study reveals possible new routes to treating osteoarthritis
January 22, 2019 - Blood test may detect early signs of lung-transplant rejection
January 22, 2019 - Blood marker could aid in early prediction of Alzheimer’s progression
January 22, 2019 - Orthodontic treatment does not guarantee future dental health
January 22, 2019 - Rutgers researchers discover cause of bone loss in people with joint replacements
January 22, 2019 - Diversity among rural Africans extends to their gut microbiomes
January 22, 2019 - Newly developed biological system lets cells to create self-curving cornea
January 22, 2019 - VTv Therapeutics Announces Publication of Comprehensive Data in Science Translational Medicine Detailing the Discovery and Clinical Development of TTP399, including Results of Phase 2 AGATA Study
January 22, 2019 - about one in three adults with prediabetes has arthritis
January 22, 2019 - A look at how data is democratizing health care
January 22, 2019 - Alcohol-Linked Disease Overtakes Hep C As Top Reason For Liver Transplant
January 22, 2019 - Researchers identify new genes linked with age-related macular degeneration
January 22, 2019 - MPFI researchers identify synaptic logic for connections between two brain hemispheres
January 22, 2019 - New study extends our knowledge of the link between miRNAs and cancer
January 22, 2019 - Asthma, eczema are not barriers to active lifestyle in teenagers
January 22, 2019 - Genetic changes may predict likelihood of relapse in breast cancer patients
January 22, 2019 - Antiepileptic drug use by people with Alzheimer’s disease linked to accumulation of hospital days
January 22, 2019 - IUPUI researcher receives $2.85 million grant to find ways to improve bone strength
January 22, 2019 - Precision medicine can help keep astronauts healthy during deep space missions
January 22, 2019 - Detecting signs of neurodegeneration earlier and more accurately
January 22, 2019 - Mouse studies challenge ‘inhibition’ theory of autism
January 22, 2019 - SSB launches BIOSTAT RM TX single-use bioreactor for producing consistent quality cellular products
January 22, 2019 - Experimental drug can positively modify key characteristic behavior in FXS patients
January 22, 2019 - Low-Income Women Lack Menstrual Hygiene Supplies
January 22, 2019 - Better mouse model built to enable precision-medicine research for Alzheimer’s
January 22, 2019 - Molecular profiling of precancerous lung lesions could lead to early detection and new treatments
January 22, 2019 - Genetic factors influence where fat is stored in our bodies
January 22, 2019 - The Psychology Behind Sticking to Your New Year’s Resolutions
January 22, 2019 - Scientists aim to find genetic causes of developmental abnormalities in the vagina and uterus
January 22, 2019 - New survey reveals scale of preventative healthcare challenge in the UK
January 22, 2019 - Looming Global Crisis Means People’s Diets Must Change: Experts
January 22, 2019 - Excessive social media use is comparable to drug addiction
January 22, 2019 - Researchers show how mechanical stress affects bone development
January 22, 2019 - Study takes a step closer to understanding the body’s response to opioid painkillers
January 22, 2019 - Unexpected connection found between feeding and memory centers of the brain
January 22, 2019 - A revolutionary approach transforms bone trauma treatment
January 22, 2019 - Early studies and recent clinical trials on nerve growth factor
January 22, 2019 - Dry Mouth and Older Adults: Information for Caregivers
January 22, 2019 - Are your grandparents getting tipsy at the holiday party?
January 22, 2019 - New machine learning algorithms identify early symptoms of urinary tract infections
January 22, 2019 - Young women skipping the Pap smear test due to embarrassment
January 22, 2019 - A global influenza pandemic high on the WHO’s agenda
January 22, 2019 - Amgen Makes All Repatha (evolocumab) Device Options Available In The US At A 60 Percent Reduced List Price
January 22, 2019 - Elastronics—hydrogel-based microelectronics for localized low-voltage neuromodulation
January 22, 2019 - Branched-chain amino acids in tumors can be targeted to prevent and treat cancer
January 22, 2019 - Fueling macrophages with energy to attack and eat cancer cells
January 22, 2019 - Amgen And UCB Receive Positive Vote From FDA Advisory Committee In Favor Of Approval For Evenity (romosozumab)
January 22, 2019 - Does being bilingual make children more focused? Study says no
January 22, 2019 - Study reveals new genes and biological pathways linked to osteoarthritis
January 22, 2019 - FSU study provides better understanding of spinal cord injuries
January 22, 2019 - Delaying bath for newborn babies increases breastfeeding rates, finds study
January 21, 2019 - WHO identifies non-communicable diseases as major threat to human health
January 21, 2019 - Many parents still try non-evidence-based cold prevention methods for children
January 21, 2019 - High Levels of Activity, Motor Ability Linked to Better Cognition
January 21, 2019 - Killer blows? Knockout study of pair of mouse MicroRNA provides cancer insight
January 21, 2019 - Buffalo researchers receive grant to quicken development of generic equivalents of contraceptives
January 21, 2019 - One-third of pregnant women do not believe cannabis is harmful to their fetus
January 21, 2019 - Fiderstat could be used as chemopreventative drug for intestinal cancers caused by APC gene mutations
January 21, 2019 - Modifying healthcare delivery practices may improve discussions between youth and healthcare providers
January 21, 2019 - UNIST researcher named as recipient of Merck’s 2018 Life Science Awards
January 21, 2019 - How Getting a Flu Shot Could Save Your Life
January 21, 2019 - Surgical adhesions can be treated, prevented in mice
January 21, 2019 - Increased physician-targeted marketing associated with higher opioid overdose deaths
January 21, 2019 - Researchers uncover specific microbial signatures of intestinal disease
January 21, 2019 - Researchers discover new blood vessel system in bones
January 21, 2019 - Simple blood test reliably detects signs of Alzheimer’s damage before symptoms
January 21, 2019 - Study to investigate new targeted oral treatments for severe asthma
January 21, 2019 - Plan Your Plate | NIH News in Health
January 21, 2019 - Fecal occult blood test may improve CRC outcomes in some
January 21, 2019 - Blood test detects Alzheimer’s disease years before symptoms develop
January 21, 2019 - Mount Sinai joins with Paradigm and ReqMed to repurpose drug for treatment of MPS
January 21, 2019 - FDA Advisory Committee Votes on Zynquista (sotagliflozin) as Treatment for Adults with Type 1 Diabetes
Metformin Found Safe in Pregnant Women With Diabetes

Metformin Found Safe in Pregnant Women With Diabetes

image_pdfDownload PDFimage_print

Action Points

  • Note that this observational study suggests that women who take metformin during pregnancy have no increased risk of adverse pregnancy outcomes, beyond those that arise through the presence of diabetes.
  • Be aware that the authors did not analyze a group of women with diabetes but not treated with metformin.

Pregnant women who took metformin for pregestational diabetes had a higher risk for adverse outcomes, but this risk was linked to the diabetes, not the drug, researchers reported.

Pregnant women on metformin for other indications, such as polycystic ovary syndrome (PCOS), had no significantly increased risk for poor outcomes, Alice Panchaud, PhD, of the University of Geneva in Switzerland, and colleagues wrote online in the British Journal of Clinical Pharmacology.

Compared with a matched reference group of pregnant women not taking metformin, metformin users with diabetes were nearly four times more likely to give birth to an infant with major birth defects (odds ratio 3.95; 95% CI 1.77 to 9.41). However, there was no significantly increased risk for pregnant women on metformin for other reasons (OR 0.83; 95% CI 0.18 to 2.81), the study found.

Similarly, women taking metformin for pre-gestational diabetes had more than twice the risk for spontaneous abortion or stillbirth (OR 2.51; 95% CI 1.44 to 4.36), but women taking metformin for other indications had no significant risk increase (OR 1.38; 95% CI 0.74 to 2.59).

The results were similar for other pregnancy outcomes the study examined, including the risk for pre-term birth and assisted delivery.

“Metformin controls glycemia in pregnant women with gestational diabetes, and it has been shown to prevent adverse maternal and neonatal outcomes associated with hyperglycemia,” Panchaud et al said. “However, evidence regarding its safety and effectiveness to achieve glycemic targets in the management of type 2 diabetes in pregnancy is limited. Moreover, since metformin, as do most other drugs, crosses the placental barrier, embryological and fetal risks need to be considered when exposure occurs early in pregnancy.”

The researchers explained that the aim of the observational cohort study was to better characterize the safety of metformin use early in pregnancy, and to evaluate the risk of birth defects and pregnancy losses after first trimester exposure to metformin. “We took advantage of the several potential indications to disentangle the effect of metformin from the known effects of diabetes on pregnancy outcomes,” the team said.

At the time of the study, Panchaud was a research fellow at the Harvard T.H. Chan School of Public Health in Boston. “Our findings provide the first reassuring evidence that metformin might offer a cheaper and simpler alternative to insulin for the management of pregestational diabetes in pregnancy when effective,” she said in a statement.

The multi-center, prospective study included 471 pregnant women who were taking metformin, enrolled from 1993 to 2015. The vast majority (97%) started metformin before pregnancy and took the drug during their first trimester. The median dose was 1,325 mg. A total of 63% of participants were taking metformin for pregestational diabetes; 12% were taking the drug for PCOS; and the remainder, for other indications such as obesity, ovary stimulation, insulin resistance, glucose intolerance, and hyperglycemia.

For a reference group, the study included 497 randomly selected pregnant women matched to the treatment group in terms of study center, maternal age, and week of gestational age at enrollment. These women had not used metformin, insulin, or any other hypoglycemic agent at any time during their pregnancy.

The team used multivariate logistic regression analysis to look for associations between metformin use and pregnancy outcomes, and importantly, distinguished between women who were taking metformin for pregestational diabetes and those taking it for other indications.

“Whether diabetes increases a woman’s risk of having a spontaneous abortion has been under debate for a long time,” the researchers wrote. “Overall, studies suggest that poor metabolic control may be at increased risk of spontaneous abortion. Similarly, in our study the risk of pregnancy losses was higher (21%) in the group exposed to metformin with a diagnostic of pregestational diabetes than in the metformin-exposed group without pregestational diabetes (17%).”

The main limitation of the study, the authors said, was the lack of a reference group of pregnant women being treated for pregestational diabetes with other drugs, especially insulin. In addition, “although this is the largest study published to date, the sample size is still too small and follow-up duration too short to reach a final assessment on the safety and risks associated with the use of metformin in pregnancy. Future studies comparing metformin-exposed pregnancies with women with the same indication and treated with alternative therapies — e.g., on insulin — are warranted.”

The study was funded by the Swiss National Science Foundation.

Panchaud and co-authors declared having no conflicts of interest.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

1969-12-31T19:00:00-0500

last updated

Tagged with:

About author

Related Articles